Adial Pharmaceuticals, Inc.
1001 Research Park Blvd., Suite 100
Charlottesville, Virginia 22911
February 19, 2019
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Todd Schiffman
|Re:||Adial Pharmaceuticals, Inc.|
Registration Statement on Form S-1, as amended
File No: 333-229615
Ladies and Gentlemen:
Adial Pharmaceuticals, Inc. (the “Registrant”) hereby requests that the effective date of the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-229615), be accelerated by the U.S. Securities and Exchange Commission to Wednesday, February 20, 2019, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant hereby authorizes its legal counsel, Leslie Marlow, Esq. of Gracin & Marlow, LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 496-2223 or (516) 457-4238 with any questions you may have concerning this request, and please notify her when this request for acceleration has been granted.
|Very truly yours,|
|ADIAL PHARMACEUTICALS, INC.|
|By:||/s/ Willian B. Stilley III|
|Name:||William B. Stilley III|
|Title:||Chief Executive Officer|
|cc:||Leslie Marlow, Esq., Gracin & Marlow, LLP|